시장보고서
상품코드
1278995

펩티드 치료제 시장 : 세계 산업 분석, 동향, 시장 규모, 예측(-2030년)

Peptide Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

발행일: | 리서치사: Infinium Global Research (IGR) | 페이지 정보: 영문 255 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 펩티드 치료제 시장 규모는 2023-2030년 예측 기간 동안 약 10%의 CAGR로 성장할 것으로 예상됩니다.

세계 펩티드 치료제 시장을 조사하여 제품 유형별, 용도별, 투여 경로별, 지역별 동향과 시장 진입 기업의 경쟁 상황 등을 정리하여 전해드립니다.

목차

제1장 서문

제2장 주요 요약

제3장 세계의 펩티드 치료제 시장 개요

  • 서론
  • 시장 역학
  • Porter's Five Forces 분석
  • IGR-성장 매트릭스 분석
  • 펩티드 치료제 시장 밸류체인 분석
  • 펩티드 치료제 시장 을 위한 TAM SAM SOM 분석

제4장 펩티드 치료제 시장 거시적 지표 분석

제5장제 세계의 펩티드 치료제 시장, 제품 유형별

  • 제네릭
  • 브랜드

제6장 세계의 펩티드 치료제 시장, 용도별

  • 위장질환
  • 신경학적 장애
  • 대사장애
  • 기타

제7장 세계의 펩티드 치료제 시장, 투여 경로별

  • 비경구
  • 경구
  • 기타

제8장 세계의 펩티드 치료제 시장, 2023-2030년, 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제9장 기업 개요와 경쟁 상황

  • 세계의 펩티드 치료제 시장 경쟁 상황
  • 기업 개요
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Sanofi
    • Pfizer Inc.
    • Novartis AG
    • GSK plc
    • F. Hoffmann-La Roche Ltd
    • Lilly
    • Bachem
    • Amgen Inc.
KSM 23.06.02

The report on the global peptide therapeutics market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global peptide therapeutics market to grow with a CAGR of Around 10% over the forecast period from 2023-2030. The study on peptide therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on peptide therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global peptide therapeutics market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global peptide therapeutics market over the period of 2021-2030. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The rising prevalence of metabolic disorders coupled with an increasing pool of cancer patients.
  • Rising research activities and the development pipeline of peptide drugs are anticipated to drive the growth of the market.

2) Restraints

  • Strict regulatory prerequisites for drug approval are expected to limit market growth.

3) Opportunities

  • The increasing incidence of metabolic disorders across the globe will also be expected to create numerous growth opportunities in the forthcoming years.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include:

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global peptide therapeutics market is segmented on the basis of product type, application, and route of administration.

The Global Peptide Therapeutics Market by Product Type

  • Generic
  • Branded

The Global Peptide Therapeutics Market by Application

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Other Application

The Global Peptide Therapeutics Market by Route of Administration

  • Parenteral
  • Oral
  • Other Routes of Administration

Company Profiles

The companies covered in the report include:

  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Pfizer Inc.
  • Novartis AG
  • GSK plc
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Bachem
  • Amgen Inc.

What does this Report Deliver?

  • 1. Comprehensive analysis of the global as well as regional markets of the peptide therapeutics market.
  • 2. Complete coverage of all the segments in the peptide therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2030.
  • 3. Comprehensive analysis of the companies operating in the global peptide therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
  • 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

Chapter 2. Executive Summary

  • 2.1. Peptide Therapeutics Market Highlights
  • 2.2. Peptide Therapeutics Market Projection
  • 2.3. Peptide Therapeutics Market Regional Highlights

Chapter 3. Global Peptide Therapeutics Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Porter`s Five Forces Analysis
  • 3.4. IGR-Growth Matrix Analysis
    • 3.4.1. IGR-Growth Matrix Analysis by Product Type
    • 3.4.2. IGR-Growth Matrix Analysis by Application
    • 3.4.3. IGR-Growth Matrix Analysis by Route of Administration
    • 3.4.4. IGR-Growth Matrix Analysis by Region
  • 3.5. Value Chain Analysis of Peptide Therapeutics Market
  • 3.6. TAM SAM SOM Analysis for Peptide Therapeutics Market
    • 3.6.1. TAM SAM SOM Forecast Analysis (USD Billion) 2023

Chapter 4. Peptide Therapeutics Market Macro Indicator Analysis

Chapter 5. Global Peptide Therapeutics Market by Product Type

  • 5.1. Generic
  • 5.2. Branded

Chapter 6. Global Peptide Therapeutics Market by Application

  • 6.1. Gastrointestinal Disorders
  • 6.2. Neurological Disorders
  • 6.3. Metabolic Disorders
  • 6.4. Cancer
  • 6.5. Other Application

Chapter 7. Global Peptide Therapeutics Market by Route of Administration

  • 7.1. Parenteral
  • 7.2. Oral
  • 7.3. Other Routes of Administration

Chapter 8. Global Peptide Therapeutics Market by Region 2023-2030

  • 8.1. North America
    • 8.1.1. North America Peptide Therapeutics Market by Product Type
    • 8.1.2. North America Peptide Therapeutics Market by Application
    • 8.1.3. North America Peptide Therapeutics Market by Route of Administration
    • 8.1.4. North America Peptide Therapeutics Market by Country
      • 8.1.4.1. The U.S. Peptide Therapeutics Market
        • 8.1.4.1.1. The U.S. Peptide Therapeutics Market by Product Type
        • 8.1.4.1.2. The U.S. Peptide Therapeutics Market by Application
        • 8.1.4.1.3. The U.S. Peptide Therapeutics Market by Route of Administration
      • 8.1.4.2. Canada Peptide Therapeutics Market
        • 8.1.4.2.1. Canada Peptide Therapeutics Market by Product Type
        • 8.1.4.2.2. Canada Peptide Therapeutics Market by Application
        • 8.1.4.2.3. Canada Peptide Therapeutics Market by Route of Administration
      • 8.1.4.3. Mexico Peptide Therapeutics Market
        • 8.1.4.3.1. Mexico Peptide Therapeutics Market by Product Type
        • 8.1.4.3.2. Mexico Peptide Therapeutics Market by Application
        • 8.1.4.3.3. Mexico Peptide Therapeutics Market by Route of Administration
  • 8.2. Europe
    • 8.2.1. Europe Peptide Therapeutics Market by Product Type
    • 8.2.2. Europe Peptide Therapeutics Market by Application
    • 8.2.3. Europe Peptide Therapeutics Market by Route of Administration
    • 8.2.4. Europe Peptide Therapeutics Market by Country
      • 8.2.4.1. Germany Peptide Therapeutics Market
        • 8.2.4.1.1. Germany Peptide Therapeutics Market by Product Type
        • 8.2.4.1.2. Germany Peptide Therapeutics Market by Application
        • 8.2.4.1.3. Germany Peptide Therapeutics Market by Route of Administration
      • 8.2.4.2. United Kingdom Peptide Therapeutics Market
        • 8.2.4.2.1. United Kingdom Peptide Therapeutics Market by Product Type
        • 8.2.4.2.2. United Kingdom Peptide Therapeutics Market by Application
        • 8.2.4.2.3. United Kingdom Peptide Therapeutics Market by Route of Administration
      • 8.2.4.3. France Peptide Therapeutics Market
        • 8.2.4.3.1. France Peptide Therapeutics Market by Product Type
        • 8.2.4.3.2. France Peptide Therapeutics Market by Application
        • 8.2.4.3.3. France Peptide Therapeutics Market by Route of Administration
      • 8.2.4.4. Italy Peptide Therapeutics Market
        • 8.2.4.4.1. Italy Peptide Therapeutics Market by Product Type
        • 8.2.4.4.2. Italy Peptide Therapeutics Market by Application
        • 8.2.4.4.3. Italy Peptide Therapeutics Market by Route of Administration
      • 8.2.4.5. Spain Peptide Therapeutics Market
        • 8.2.4.5.1. Spain Peptide Therapeutics Market by Product Type
        • 8.2.4.5.2. Spain Peptide Therapeutics Market by Application
        • 8.2.4.5.3. Spain Peptide Therapeutics Market by Route of Administration
      • 8.2.4.6. Rest of Europe Peptide Therapeutics Market
        • 8.2.4.6.1. Rest of Europe Peptide Therapeutics Market by Product Type
        • 8.2.4.6.2. Rest of Europe Peptide Therapeutics Market by Application
        • 8.2.4.6.3. Rest of Europe Peptide Therapeutics Market by Route of Administration
  • 8.3. Asia Pacific
    • 8.3.1. Asia Pacific Peptide Therapeutics Market by Product Type
    • 8.3.2. Asia Pacific Peptide Therapeutics Market by Application
    • 8.3.3. Asia Pacific Peptide Therapeutics Market by Route of Administration
    • 8.3.4. Asia Pacific Peptide Therapeutics Market by Country
      • 8.3.4.1. China Peptide Therapeutics Market
        • 8.3.4.1.1. China Peptide Therapeutics Market by Product Type
        • 8.3.4.1.2. China Peptide Therapeutics Market by Application
        • 8.3.4.1.3. China Peptide Therapeutics Market by Route of Administration
      • 8.3.4.2. Japan Peptide Therapeutics Market
        • 8.3.4.2.1. Japan Peptide Therapeutics Market by Product Type
        • 8.3.4.2.2. Japan Peptide Therapeutics Market by Application
        • 8.3.4.2.3. Japan Peptide Therapeutics Market by Route of Administration
      • 8.3.4.3. India Peptide Therapeutics Market
        • 8.3.4.3.1. India Peptide Therapeutics Market by Product Type
        • 8.3.4.3.2. India Peptide Therapeutics Market by Application
        • 8.3.4.3.3. India Peptide Therapeutics Market by Route of Administration
      • 8.3.4.4. South Korea Peptide Therapeutics Market
        • 8.3.4.4.1. South Korea Peptide Therapeutics Market by Product Type
        • 8.3.4.4.2. South Korea Peptide Therapeutics Market by Application
        • 8.3.4.4.3. South Korea Peptide Therapeutics Market by Route of Administration
      • 8.3.4.5. Australia Peptide Therapeutics Market
        • 8.3.4.5.1. Australia Peptide Therapeutics Market by Product Type
        • 8.3.4.5.2. Australia Peptide Therapeutics Market by Application
        • 8.3.4.5.3. Australia Peptide Therapeutics Market by Route of Administration
      • 8.3.4.6. Rest of Asia-Pacific Peptide Therapeutics Market
        • 8.3.4.6.1. Rest of Asia-Pacific Peptide Therapeutics Market by Product Type
        • 8.3.4.6.2. Rest of Asia-Pacific Peptide Therapeutics Market by Application
        • 8.3.4.6.3. Rest of Asia-Pacific Peptide Therapeutics Market by Route of Administration
  • 8.4. RoW
    • 8.4.1. RoW Peptide Therapeutics Market by Product Type
    • 8.4.2. RoW Peptide Therapeutics Market by Application
    • 8.4.3. RoW Peptide Therapeutics Market by Route of Administration
    • 8.4.4. RoW Peptide Therapeutics Market by Sub-region
      • 8.4.4.1. Latin America Peptide Therapeutics Market
        • 8.4.4.1.1. Latin America Peptide Therapeutics Market by Product Type
        • 8.4.4.1.2. Latin America Peptide Therapeutics Market by Application
        • 8.4.4.1.3. Latin America Peptide Therapeutics Market by Route of Administration
      • 8.4.4.2. Middle East Peptide Therapeutics Market
        • 8.4.4.2.1. Middle East Peptide Therapeutics Market by Product Type
        • 8.4.4.2.2. Middle East Peptide Therapeutics Market by Application
        • 8.4.4.2.3. Middle East Peptide Therapeutics Market by Route of Administration
      • 8.4.4.3. Africa Peptide Therapeutics Market
        • 8.4.4.3.1. Africa Peptide Therapeutics Market by Product Type
        • 8.4.4.3.2. Africa Peptide Therapeutics Market by Application
        • 8.4.4.3.3. Africa Peptide Therapeutics Market by Route of Administration

Chapter 9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Peptide Therapeutics Market
  • 9.2. Companies Profiles
    • 9.2.1. Teva Pharmaceutical Industries Ltd.
    • 9.2.2. Takeda Pharmaceutical Company Limited
    • 9.2.3. Sanofi
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Novartis AG
    • 9.2.6. GSK plc
    • 9.2.7. F. Hoffmann-La Roche Ltd
    • 9.2.8. Lilly
    • 9.2.9. Bachem
    • 9.2.10. Amgen Inc.
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제